Genetic variation and heritability estimation in Jatropha curcas L. progenies for seed yield and vegetative traits

In this study, experiment was conducted on sandy loam soils poor in organic carbon and water holding capacity in southern Haryana, India to determine the best progenies of Jatropha curcas for bio-diesel production. Fifty progenies raised from seed sources collected from nine states of India were evaluated after five years of plantation for growth, seed and oil content traits. The progenies showed significant (P> 0.05) differences for all the traits studied. Maximum seed yield/plant (879.37 g), number of capsules/plant (522.67) and plant height (408.33 cm) was recorded in P-44. Maximum oil content observed in P-37 (36.08%) followed by P-5 (35.64%). The magnitude of phenotypic coefficient of variation (PCV) was higher than the corresponding genotypic coefficient of variation (GCV) for all the characters studied. Heritability was highest for oil content (95.49%) and 100-seed weight (87.75%) followed by seed yield (75.54%). Total capsules/plant exhibited highest genetic advance (92.69%) followed by number of branches per plant (64.32%). Hierarchical Euclidean cluster analysis of all 50 progenies using D2 statistics was done where the D2 analysis grouped the progenies into five clusters. The intra cluster distances ranged from 1.33 to 2.72. The maximum inter-cluster distance was observed between cluster II and V (6.43) followed by I and V indicating greater divergence among progenies belonging to these clusters and an attempt to cross the progenies in these clusters should bring out desirable gene combinations. These progenies showed considerable potential which can be tapped for planting and selecting the improved varieties

SWI/SNF regulates a transcriptional programme that induces senescence to prevent liver cancer

Oncogene-induced senescence (OIS) is a potent tumour suppressor mechanism. To identify senescence regulators relevant to cancer, we screened an shRNA library targeting genes deleted in hepatocellular carcinoma (HCC). Here, we describe how knockdown of the SWI/SNF component ARID1B prevents OIS and cooperates with RAS to induce liver tumours. ARID1B controls p16INK4a and p21CIP1a transcription but also regulates DNA damage, oxidative stress and p53 induction, suggesting that SWI/SNF uses additional mechanisms to regulate senescence. To systematically identify SWI/SNF targets regulating senescence, we carried out a focused shRNA screen. We discovered several new senescence regulators including ENTPD7, an enzyme that hydrolyses nucleotides. ENTPD7 affects oxidative stress, DNA damage and senescence. Importantly, expression of ENTPD7 or inhibition of nucleotide synthesis in ARID1B-depleted cells results in re-establishment of senescence. Our results identify novel mechanisms by which epigenetic regulators can affect tumor progression and suggest that pro-senescence therapies could be employed against SWI/SNF-mutated cancers

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure

Inder S Anand1, Anita Deswal2, Dean J Kereiakes3, Das Purkayastha4, Dion H Zappe41Veterans Administration Medical Center, Minneapolis, MN, USA; 2Michael E DeBakey VA Medical Center, Houston, TX, USA; 3The Christ Hospital Heart and Vascular Center, Cincinnati, OH, USA; 4Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; Clinical trial registration information: www.clinicaltrials.gov/ct2/show/NC T00294086 Unique identification number: NC T00294086Background: The safety of once-daily (qd) dosing of valsartan in heart failure (HF) patients is not known. Hypothesis: This 10-week, double-blind trial examined the relative safety and efficacy of valsartan administered qd versus twice-daily (bid).Methods: HF patients (NYHA class II–III) receiving diuretics (87%), angiotensin-converting enzyme inhibitors (98%), beta-blockers (92%), aldosterone antagonists (25%), or digoxin (32%) were randomized to valsartan 40 mg bid (n = 60) or 80 mg qd (n = 55) and titrated to a maximum dose of 320 mg/day; doubling the dose every 2 weeks. Clinical and biochemical parameters were measured at Weeks 2, 4, 6, and 10.Results: The average dose of valsartan at the end of study was 245 mg in the bid group vs 256 mg in the qd group (P = NS). Similar proportions of patients tolerated qd vs bid dosing (bid 67% vs qd 68%). Outcome measures including reduction in blood pressure, incidence of hypotension, renal impairment, orthostatic dizziness or fatigue, changes in serum K+, creatinine, cystatin-C, and estimated glomerular filtration rate were similar between the 2 groups at all time-points. Brain natriuretic peptide levels decreased and plasma renin activity increased from baseline by the same amount in both groups at all time-points.Conclusion: Valsartan administered qd has a similar safety and tolerability profile with comparable 24-hour RAAS blockade, as assessed by increases in PRA, as bid dosing in patients with moderate to severe (NYHA class II–III) heart failure.Keywords: heart failure, angiotensin receptor blocker, valsarta

Curcumin: A medicinal plant and its effects in medicine and dentistry

Since ancient time plants have been a major source of medicine. Curcumin (diferuloylmethane) is an orange-yellow component of turmeric (Curcuma longa), a spice often found in curry powder. Traditionally known for its anti-inflammatory effects, C. longa has a long history of the curative use in the Ayurvedic and Chinese systems of medicine. Curcumin, a polyphenolic constituent, is the active ingredient in dietary spice turmeric. While numerous pharmacological activities, including antioxidant and antimicrobial properties, anti-inflammatory properties have been attributed to curcumin, turmeric can also be used as a pit and fissure sealant, mouthwash, and subgingival irrigant in various preparations. In gel form, it is a component in local drugs delivery system. This review gives a bird’s eye view mainly on the biological activities of the miswak and plausible medicinal and dental application

Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design

Background Heart failure (HF) and diabetes (DM) are a lethal combination. The current armamentarium of anti-diabetic agents has been shown to be less efficacious and sometimes even harmful in diabetic patients with concomitant cardiovascular disease, especially HF. Sodium glucose linked co-transporter type 2 (SGLT2) inhibitors are a new class of anti-diabetic agent that has shown potentially beneficial cardiovascular effects such as pre-load and after load reduction through osmotic diuresis, blood pressure reduction, reduced arterial stiffness and weight loss. This has been supported by the recently published EMPA-REG trial which showed a striking 38 and 35 % reduction in cardiovascular death and HF hospitalisation respectively. Methods The REFORM trial is a novel, phase IV randomised, double blind, placebo controlled clinical trial that has been ongoing since March 2015. It is designed specifically to test the safety and efficacy of the SLGT2 inhibitor, dapagliflozin, on diabetic patients with known HF. We utilise cardiac-MRI, cardio-pulmonary exercise testing, body composition analysis and other tests to quantify the cardiovascular and systemic effects of dapagliflozin 10 mg once daily against standard of care over a 1 year observation period. The primary outcome is to detect the change in left ventricular (LV) end systolic and LV end diastolic volumes. The secondary outcome measures include LV ejection fraction, LV mass index, exercise tolerance, fluid status, quality of life measures and others. Conclusions This trial will be able to determine if SGLT2 inhibitor therapy produces potentially beneficial effects in patients with DM and HF, thereby replacing current medications as the drug of choice when treating patients with both DM and HF

Screening of winery and olive mill wastes for lignocellulolytic enzyme production from Aspergillus species by solid-state fermentation

Wastes from olive oil and wine industries (as exhausted grape marc, vineshoot trimmings, two-phase olive mill waste, vinasses, and olive mill wastewater) were evaluated for lignocellulolytic enzyme production (as endocellulases, endoxylanases, and feruloyl esterases) by solid-state fermentation (SSF) with Aspergillus niger, Aspergillus ibericus, and Aspergillus uvarum. To study the effect of different solid medium composition and time in enzyme production, a PlackettBurman experimental design was used. Variables that had a higher positive effect in lignocellulolytic enzyme production were urea, time, and exhausted grape marc. The maximum values of enzymatic activity per unit of substrate dry mass were found with A. niger for feruloyl esterase. Enzymatic extracts from SSF with A. niger achieved maximum feruloyl esterase activity (89.53 U/g) and endoxylanase activity (3.06 U/g) and with A. uvarum for endocellulase activity (6.77 U/g). The enzyme cocktails obtained in the SSF extracts may have applications in biorefinery industries.Jose Manuel Salgado is grateful for the postdoctoral fellowship (EX-2010-0402) of the Education Ministry of Spanish Government. Luis Abrunhosa was supported by the grant SFRH/BPD/43922/2008 from Fundacao para a Ciencia e Tecnologia-FCT, Portugal

Early diagnosis of congenital methemoglobinemia type 1 in a 4-year-old child

Bluish discoloration of the skin and mucous membrane is known as cyanosis which is a clinical sign that occurs in many diseases. Thecauses of central cyanosis are cardiac shunts causing mixing of oxygenated and deoxygenated blood, lung diseases with ventilationperfusionmismatch, polycythemia, and methemoglobinemia. Methemoglobin is the oxidized form of hemoglobin, which doesnot bind oxygen and increases the affinity of oxygen for the partially oxidized portion of hemoglobin. Methemoglobinemia maybe congenital or acquired (usually drug induced). Congenital methemoglobinemia is a very rarely reported disease that is causedby a deficiency of nicotinamide adenine dinucleotide phosphate-cytochrome b5 reductase enzyme deficiency or by an abnormalhemoglobin called hemoglobin H. Acquired methemoglobinemia is caused by drugs, namely the sulfonamide group and localanesthetics such as benzocaine and prilocaine. Here, we present the case of a 4-year-old girl who presented with complaints ofbluishness of the fingers and lips without any other associated symptoms and later on diagnosed as congenital methemoglobinemi

Harnessing the potential of ligninolytic enzymes for lignocellulosic biomass pretreatment

Abundant lignocellulosic biomass from various industries provides a great potential feedstock for the production of value-added products such as biofuel, animal feed, and paper pulping. However, low yield of sugar obtained from lignocellulosic hydrolysate is usually due to the presence of lignin that acts as a protective barrier for cellulose and thus restricts the accessibility of the enzyme to work on the cellulosic component. This review focuses on the significance of biological pretreatment specifically using ligninolytic enzymes as an alternative method apart from the conventional physical and chemical pretreatment. Different modes of biological pretreatment are discussed in this paper which is based on (i) fungal pretreatment where fungi mycelia colonise and directly attack the substrate by releasing ligninolytic enzymes and (ii) enzymatic pretreatment using ligninolytic enzymes to counter the drawbacks of fungal pretreatment. This review also discusses the important factors of biological pretreatment using ligninolytic enzymes such as nature of the lignocellulosic biomass, pH, temperature, presence of mediator, oxygen, and surfactant during the biodelignification process

In silico docking studies of Yucca gloriosa L. phytoconstituents with TNF-α, IL-6 and IL-13 receptor against Asthma

Yucca gloriosa L has been comprehensively assessed in vitro and in vivo for its action against asthma Y gloriosa L is a rich source of phenolic compounds such as gloriosaols A E and yuccaols A E which exhibit potent antioxidant activity Gloriosaols A E and yuccaols A E are structurally related to corticosteroids The current study describes the in silico docking of some important anti asthmatic phytoconstituents from the plant Y gloriosa L with molecular targets of asthma Toward the recognition of the binding methods of these pharmacologically dynamic components molecular modelling studies were carried out with target proteins i e interleukin IL 6 1N26 IL 13 3LB6 and TNF 2AZ5 using in silico molecular docking The components demonstrated encouraging binding interactions with the amino acid residues at the active sites of these proteins authenticating their verified efficiency as anti asthmatic agents The current research in addition provides insight into the possible herbal drug receptor interaction and synthetic drug montelukast sodium receptor interaction for the possible management of asthma ScienceIn Publishing ISSN 2347 982